Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases

Science Signaling

Volumn 3, Issue 146, 2010, Pages

  Shi, Michael A ^a   Shi, Guo Ping ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHEMOKINE RECEPTOR CXCR4; MICRORNA; MICRORNA 122; MICRORNA 126; MICRORNA 132; MICRORNA 150; MICRORNA 33; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL INFILTRATION; DISEASE COURSE; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; INTRON; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTICLE; DRUG DELIVERY SYSTEM; MOUSE; RAT;

ANIMALIA;

ANIMALS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICRORNAS; RATS;

EID: 78049515829     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.3146pe40     Document Type: Review

References (45)

1. T. A. Harris, M. Yamakuchi, M. Ferlito, J. T. Mendell, C. J. Lowenstein, MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 105, 1516-1521 (2008).
2. J. E. Fish, M. M. Santoro, S. U. Morton, S. Yu, R. F.Yeh, J. D.Wythe, K. N. Ivey, B. G. Bruneau, D.Y. Stainier, D. Srivastava, miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272-284 (2008).
3. M. Lagos-Quintana, R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, T. Tuschl, Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739 (2002).
4. R. Ji, Y. Cheng, J. Yue, J. Yang, X. Liu, H. Chen, D. B. Dean, C. Zhang, MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 100, 1579-1588 (2007).
5. A. Krek, D. Grün, M. N. Poy, R. Wolf, L. Rosenberg, E. J. Epstein, P. MacMenamin, I. da Piedade, K. C. Gunsalus, M. Stoffel, N. Rajewsky, Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005).
6. A. Carè, D. Catalucci, F. Felicetti, D. Bonci, A. Addario, P. Gallo, M. L. Bang, P. Segnalini, Y. Gu, N. D. Dalton, L. Elia, M. V. Latronico, M. Høydal, C. Autore, M. A. Russo, G. W. Dorn II, Ø. Ellingsen, P. Ruiz-Lozano, K. L. Peterson, C. M. Croce, C. Peschle, G. Condorelli, MicroRNA-133 controls cardiac hypertrophy. Nat.Med. 13, 613-618 (2007).
7. Y. Fang, C. Shi, E. Manduchi, M. Civelek, P. F. Davies, MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 107, 13450-13455 (2010).
8. C. Zhang, MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease. Cell Cycle 8, 3469-3473 (2009).
9. Y. Cheng, X. Liu, J. Yang, Y. Lin, D. Z. Xu, Q. Lu, E. A. Deitch, Y. Huo, E. S. Delphin, C. Zhang, MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 105, 158-166 (2009).
10. M. M. Martin, J. A. Buckenberger, J. Jiang, G. E. Malana, G. J. Nuovo, M. Chotani, D. S. Feldman, T. D. Schmittgen, T. S. Elton, The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J. Biol. Chem. 282, 24262-24269 (2007).
11. E. van Rooij, L. B. Sutherland, N. Liu, A. H. Williams, J. McAnally, R. D. Gerard, J. A. Richardson, E. N. Olson, A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U.S.A. 103, 18255-18260 (2006).
12. Y. Suárez, C. Fernández-Hernando, J. S. Pober, W. C. Sessa, Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100, 1164-1173 (2007).
13. Y. Cheng, R. Ji, J.Yue, J.Yang, X. Liu, H. Chen, D. B. Dean, C. Zhang, MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hyper trophy? Am. J. Pathol. 170, 1831-1840 (2007).
14. S. Roy, S. Khanna, S. R. Hussain, S. Biswas, A. Azad, C. Rink, S. Gnyawali, S. Shilo, G. J. Nuovo, C. K. Sen, MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.Cardiovasc. Res. 82, 21-29 (2009).
15. D. Sayed, S. Rane, J. Lypowy, M. He, I. Y. Chen, H. Vashistha, L. Yan, A. Malhotra, D. Vatner, M. Abdellatif, MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol. Biol. Cell 19, 3272-3282 (2008).
16. T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, M. Castoldi, J. Soutschek, V. Koteliansky, A. Rosenwald, M. A. Basson, J. D. Licht, J. T. Pena, S. H. Rouhanifard, M. U. Muckenthaler, T. Tuschl, G. R. Martin, J. Bauersachs, S. Engelhardt, MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
17. J. Elmén, M. Lindow, S. Schütz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjärn, H. F. Hansen, U. Berger, S. Gullans, P. Kearney, P. Sarnow, E. M. Straarup, S. Kauppinen, LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
18. J. Krützfeldt, N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, M. Stoffel, Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
19. C. Esau, S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey, M. Pear, L. Watts, S. L. Booten, M. Graham, R. McKay, A. Subramaniam, S. Propp, B. A. Lollo, S. Freier, C. F. Bennett, S. Bhanot, B. P. Monia, miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98 (2006).
20. J. Krützfeldt, S. Kuwajima, R. Braich, K. G. Rajeev, J. Pena, T. Tuschl, M. Manoharan, M. Stoffel, Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35, 2885-2892 (2007).
21. E. Song, P. Zhu, S. K. Lee, D. Chowdhury, S. Kussman, D. M. Dykxhoorn, Y. Feng, D. Palliser, D. B. Weiner, P. Shankar, W. A. Marasco, J. Lieberman, Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23, 709-717 (2005).
22. S. Anand, B. K. Majeti, L. M. Acevedo, E. A. Murphy, R. Mukthavaram, L. Scheppke, M. Huang, D. J. Shields, J. N. Lindquist, P. E. Lapinski, P. D. King, S. M. Weis, D. A. Cheresh, MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16, 909-914 (2010).
23. J. Kota, R. R. Chivukula, K. A. O'Donnell, E. A. Wentzel, C. L. Montgomery, H. W. Hwang, T. C. Chang, P. Vivekanandan, M. Torbenson, K. R. Clark, J. R. Mendell, J. T. Mendell, Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017 (2009).
24. K. J. Rayner, Y. Suárez, A. Dávalos, S. Parathath, M. L. Fitzgerald, N. Tamehiro, E. A. Fisher, K. J. Moore, C. Fernández- Hernando, MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
25. Y. Zhao, E. Samal, D. Srivastava, Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220 (2005).
26. J. D. Horton, J. L. Goldstein, M. S. Brown, SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002).
27. A. R. Tall, L.Yvan-Charvet, N. Terasaka, T. Pagler, N.Wang, HDL, ABC transporters, and cholesterol efflux: Impl ications for the treatment of atherosclerosis. Cell Metab. 7, 365-375 (2008).
28. F. Kuhner t, M. R. Mancuso, J. Hampton, K. Stankunas, T. Asano, C. Z. Chen, C. J. Kuo, Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-1 26. Development 135, 3989-3993 (2008).
29. S. Wang, A. B. Aurora, B. A. Johnson, X. Qi, J. McAnally, J. A. Hill, J. A. Richardson, R. Bassel-Duby, E. N. Olson, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271 (2008).
30. A. Zernecke, K. Bidzhekov, H. Noels, E. Shagdarsuren, L. Gan, B. Denecke, M. Hristov, T. Köppel, M. N. Jahantigh, E. Lutgens, S.Wang, E. N. Olson, A. Schober, C. Weber, Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81 (2009).
31. J. K. Damås, T. Waehre, A. Yndestad, T. Ueland, F. Müller, H. G. Eiken, A. M. Holm, B. Halvorsen, S. S. Frøland, L. Gullestad, P. Aukrust, Stromal cell-derived factor-1alpha in unstable angina: Potential antiinflammatory and matrix-stabilizing effects. Circulation 106, 36-42 (2002).
32. N. Werner, S. Wassmann, P. Ahlers, S. Kosiol, G. Nickenig, Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26, 112-116 (2006).
33. M. Hristov, W. Erl, S. Linder, P. C.Weber, Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104, 2761-2766 (2004).
34. M. Berthebaud, C. Rivière, P. Jarrier, A. Foudi, Y. Zhang, D. Compagno, A. Galy, W. Vainchenker, F. Louache, RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood 106, 2962-2968 (2005).
35. A. Zernecke, A. Schober, I. Bot, P. von Hundelshausen, E. A. Liehn, B. Möpps, M. Mericskay, P. Gierschik, E. A. Biessen, C. Weber, SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 96, 784-791 (2005).
36. I. Bot, S. C. de Jager, A. Zernecke, K. A. Lindstedt, T. J. van Berkel, C.Weber, E. A. Biessen, Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein Edeficient mice. Circulation 115, 2516-2525 (2007).
37. A. S. Leroyer, H. Isobe, G. Lesèche, Y. Castier, M. Wassef, Z. Mallat, B. R. Binder, A. Tedgui, C. M. Boulanger, Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 49, 772-777 (2007).
38. A. Zernecke, I. Bot, Y. Djalali-Talab, E. Shagdarsuren, K. Bidzhekov, S. Meiler, R. Krohn, A. Schober, M. Sperandio, O. Soehnlein, J. Bornemann, F. Tacke, E. A. Biessen, C. Weber, Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102, 209-217 (2008).
39. Y. Zhang, D. Liu, X. Chen, J. Li, L. Li, Z. Bian, F. Sun, J. Lu, Y. Yin, X. Cai, Q. Sun, K.Wang, Y. Ba, Q.Wang, D.Wang, J.Yang, P. Liu, T. Xu, Q.Yan, J. Zhang, K. Zen, C. Y. Zhang, Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133-144 (2010).
40. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, C. Y. Zhang, Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006 (2008).
41. P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K.Wyman, E. L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K. C. O'Briant, A. Allen, D. W. Lin, N. Urban, C. W. Drescher, B. S. Knudsen, D. L. Stirewalt, R. Gentleman, R. L. Vessella, P. S. Nelson, D. B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518 (2008).
42. E. Cocucci, G. Racchetti, M. Rupnik, J. Meldolesi, The regulated exocytosis of enlargeosomes is mediated by a SNARE machinery that includes VAMP4. J. Cell Sci. 121, 2983-2991 (2008).
43. C. Xiao, D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, K. Rajewsky, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146-159 (2007).
44. D. J. Gibbings, C. Ciaudo, M. Erhardt, O. Voinnet, Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity.Nat. Cell Biol. 11, 1143-1149 (2009).
45. Acknowledgments: We thank C. Weber (RWTH Aachen University, Germany), C.-Y. Zhang (Nanjing University, China), and X. Sun (Harvard Medical School, USA) for their critical reading. Funding: This work is supported by grants from NIH (HL60942, HL81090, and HL88547) and the Established Investigator Award from the American Heart Association (0840118N) to G.-P.S.